Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 4Sarcoma 3Genitourinary 3Gastrointestinal 2Thoracic 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Carcinoma, Renal Cell 2Prostatic Neoplasms 1Kidney Neoplasms 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Semaxinib × Genitourinary × Clear all
NCT00006002 2013-09-05

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

University of Chicago

Phase 2 Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT00009919 2013-01-23

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

National Cancer Institute (NCI)

Phase 2 Terminated
50 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00006384 2011-10-20

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

City of Hope Medical Center

Phase 2 Completed
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡